Therefore, in this study, we investigated whether the inhibition of DKK1 using WAY-262611 (WAY), a small molecule DKK1 inhibitor, enhances the anti-tumor efficacy of SOR in HCC. Here, DKK1 is linked to hepatocellular carcinoma.